Stock Events

Becton Dickinson 

$237.3
482
+$4.52+1.94% Friday 20:00

Statistics

Day High
239.22
Day Low
232.38
52W High
281.1
52W Low
218.75
Volume
1,376,600
Avg. Volume
1,331,283
Mkt Cap
68.58B
P/E Ratio
52.38
Dividend Yield
1.6%
Dividend
3.8

Upcoming

Dividends

1.6%Dividend Yield
10Y Growth
5.45%
5Y Growth
4.16%
3Y Growth
4.19%
1Y Growth
3.26%

Earnings

2MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
2.4
2.74
3.08
3.42
Expected EPS
2.97
Actual EPS
3.17

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BDX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap101.91B
Medtronic competes directly with Becton Dickinson in the medical devices sector, particularly in areas like surgical instruments and diabetes care products.
Abbott Laboratories
ABT
Mkt Cap177.49B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products that compete with Becton Dickinson's offerings.
Thermo Fisher Scientific
TMO
Mkt Cap203.97B
Thermo Fisher Scientific competes in the supply of laboratory equipment and consumables, directly challenging Becton Dickinson's life sciences segment.
Danaher
DHR
Mkt Cap180.39B
Danaher Corporation's life sciences and diagnostics divisions offer products that compete with Becton Dickinson's portfolio, especially in diagnostics and research.
Stryker
SYK
Mkt Cap129.88B
Stryker Corporation is a competitor in the medical technology field, particularly in surgical equipment and hospital beds, areas where Becton Dickinson also operates.
Boston Scientific
BSX
Mkt Cap114.03B
Boston Scientific Corporation competes with Becton Dickinson in the medical devices market, especially in areas like cardiovascular and endoscopy products.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson's medical devices division offers products that compete across several of Becton Dickinson's key areas, including surgical instruments and infection prevention.
Hologic
HOLX
Mkt Cap18.23B
Hologic, Inc. competes with Becton Dickinson in the diagnostics and women's health sectors, offering similar products for cancer detection and surgical procedures.
Zimmer Biomet
ZBH
Mkt Cap22.73B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which overlaps with Becton Dickinson's solutions for surgical and rehabilitation products.
Intuitive Surgical
ISRG
Mkt Cap161.39B
Intuitive Surgical, Inc. competes with Becton Dickinson in the surgical instruments market, particularly with its robotic-assisted surgical systems.

Analyst Ratings

287.75$Average Price Target
The highest estimate is $312.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Show more...
CEO
Thomas Polen
Employees
70000
Country
US
ISIN
US0758871091
WKN
000857675

Listings